A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT
NCT ID: NCT00350506
Last Updated: 2019-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
77 participants
INTERVENTIONAL
2005-10-31
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain
NCT00348569
Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization
NCT01810198
Dual Energy Cardiac CT Data Collection and Evaluation
NCT05171764
Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation
NCT02007967
Mechanistic Clinical Trial of Advanced Imaging for CRT
NCT03398369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
64 Channel VCT
All subjects underwent Coronary Computed Tomographic Angiography (CCTA) after receiving an intravenous (IV) administration of Visipaque (320 mgI/mL), to be followed by catheter coronary angiography (CATH).
64 Channel VCT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
64 Channel VCT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective diagnostic catheterization has been performed within the past 2 weeks but no less than 24 hours prior to the coronary CTA procedure with no intervention performed or change of the patient clinical status.
* Age ≥18 years but ≤75 years.
Exclusion Criteria
* Prior coronary artery bypass grafting or other heart surgery
* Prior pacemaker or internal defibrillator lead implantation
* Prior artificial heart valve
* Biochemical renal insufficiency (CrSerum \> 1.6) or on dialysis
* Resting HR \> 100 at the time of enrollment
* Contraindication to β-blockade or calcium channel blocker
* NYHA-IV
* High-grade atrioventricular (AV) block
* Systolic blood pressure \<90 mm Hg
* Severe asthma or active bronchospasm and/or chronic obstructive pulmonary disease
* Atrial fibrillation
* Inability to provide informed consent
* Evidence of ongoing or active clinical instability
* Acute chest pain (sudden onset)
* Acute myocardial infarction
* Cardiac shock
* Acute pulmonary edema
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GE Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Centofanti, MS
Role: STUDY_DIRECTOR
GE Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GE Healthcare
Princeton, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VCT-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.